- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The Federal Energy Regulatory Commission hasn't been able to approve new pipelines since Feb. 3, but a hearing is scheduled Tuesday to approve two nominees necessary for a voting quorum.
Insiders at Bioverativ, Juno Therapeutics and three other companies have been buying up shares of their own stock recently.
The pro-pipeline party in Canada's third largest province no longer has a majority.
Here are Friday's top research calls, including an upgrade for Costco and new coverage of McDonald's, GW Pharma and Kinder Morgan.